Clinical Trial Update: Feasibility Trial of a Sub-conjunctival Insert [NA]

View source ↗

Summary

EyeSense GmbH's feasibility trial of a sub-conjunctival insert for diabetes mellitus was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Sub-conjunctival insert

Snippet

Sponsor: EyeSense GmbH | Conditions: Diabetes (DM) | NA | Status: TERMINATED